Uterine Fibroids Operated in the Obstetric Gynecology Department of the Mother-Child Department at the University Hospital of Tengandogo: About 109 Cases
Background:Uterine fibroid is the most common benign gynecological tumor in women of
childbearing age and is common in our context. It can be discovered
incidentally or by metrorrhagia. Objective: To study the
epidemiological, clinical, therapeutic and prognostic aspects of uterine
fibroids operated in the gynaecology and obstetrics department of the CHU-T. Patients
and Method: This was a descriptive cross-sectional study including all
patients operated on for uterine fibromyoma in the gynaecology-obstetrics
department. The collection mode was retrospective, over a 5-year period from
January 1, 2017 to December 31, 2021 in the mother-child department of the
CHU-T. Data entry and analysis were carried out on a microcomputer using Epi
info 7.2.5 software. Results: We collected 109 cases of uterine fibroids
which represented 42.5% of the surgical activities of the gynaecology
department. The average age of the patients was 38.9 years ±7.8. Married women
represented 77.1%. Salaried women accounted for 65.1%. The main reasons for
consultation were uterine haemorrhage (53.1%), pelvic pain (40.4%) and
hypofertility (31.2%). Ultrasound was performed in all patients to help map the
fibroid nuclei. The main indication for surgery was haemorrhagic myoma (43.1%).
The surgical treatment was conservative (myomectomy) in 58.7% of cases and
radical (hysterectomy) in 27.4% of cases. The most frequent postoperative
complication was vulvar haemorrhage and the average hospital stay was 4 days ±
1.4. Anatomical pathological examination of the surgical excision specimen
carried out on 30 operated patients concluded that uterine leiomyoma was
diagnosed in 100% of cases. Conclusion: Patient education for early
detection, universal health insurance and cost subsidies could improve the
management of this condition.
References
[1]
Nizard, J. (2005) Pelvic Swelling in Women. Gynecology-Obstetrics the Hippocrates Collection. 215.
[2]
Fernandez, H., Gervaise, A. and De Tayrac, R. (2002) Uterine Fibroids. EMC: Gynecology, 570.
[3]
Beckmann, C.R.B., Ling, F.W., Herbert, W.N.P., et al. (2013) Obstetrics and Gynecology. 7th Edition, Wolters Kluwer Health, Philadelphia, 544.
[4]
Give, J., Vazquez, F., Tomaszewski, J., et al. (2014) Long-Term Treatment of Uterine Fibroids with Ulipristal Acetate. Fertility and Sterility, 101, 9-18.
https://doi.org/10.1016/j.fertnstert.2014.02.008
[5]
Downes, E., Sikirica, V., Gilabert-Estelles, J., et al. (2010) The Burden of Uterine Fibroids in Five European Countries. The European Journal of Obstetrics & Gynecology and Reproductive Biology, 152, 96-102.
https://doi.org/10.1016/j.ejogrb.2010.05.012
[6]
Baldé, Diallo, B.S., Conté, I., et al. (2015) Uterine Fibromyomas: Epidemiological Aspects, Clinical, Surgical Management and Prognosis at the University Hospital of Conakry. Revue Internationale des Sciences Médicales d’Abidjan, 17, 20-26.
[7]
Coulibaly, A., Sima, M., Traoré, M.S., et al. (2020) The Place of Uterine Fibroids in Patients Who Consult for Infertility at the Gynecology-Obstetrics Department of the CHU Point G. Malian Journal of Science and Technology, 1, 17-26.
[8]
Lansac, J. and Marret, H. (2018) Uterine Myomas. In: Gynecology for the Practitioner, 9th Edition, Elsevier Masson, Paris, 65-82.
[9]
Laughlin, S.K., Shroerder, J.C. and Baird, D.D. (2010) New Directions in the Epidemiology of Uterine Fibroids. Seminars in Reproductive Medicine, 28, 204-217.
https://doi.org/10.1055/s-0030-1251477
[10]
Racinet, C. (2009) Epidemiology, Risk Factors and Symptomatology of Uterine Myomas. Médecine de la Reproduction, 11, 118-122.
[11]
Tiemtoré-Kambou, B.M.A., Baguiya, A., Lamien, P.D., et al. (2021) Myoma, Fortuitous Discovery or Metrorrhagia: Who Says Better? The Pan African Medical Journal, 38, 388. https://doi.org/10.11604/pamj.2021.38.388.20314
[12]
Koffi, A.B.D., Olou, N.L., Fomba, M., et al. (2013) Uterine Fibroid Surgery: Review of Five Years of Activity in the Gynecology Department of the Yopougon University Hospital (Abidjan). Revue International des Sciences Médicales, 15, 95-99.
[13]
AitBenkaddour, Y., Gervaiseb, A. and Fernandez, H. (2010) Exploration of the Uterine Cavity in the Infertility Assessment: Which Examination to Choose. Journal of Gynecology Obstetrics and Human Reproduction, 30, 30-37.
[14]
Fernandez, H., Buffet Chabbert, N. and Allouche, S. (2014) Prevalence of Uterine Fibroids in France and Impact on Quality of Life from a Survey of 2500 Women Aged 30 - 55. Journal of Gynecology Obstetrics and Human Reproduction, 43, 721-727. https://doi.org/10.1016/j.jgyn.2014.07.006
[15]
Foulot, H., Chopin, N., Malartic, C., et al. (2005) Myomectomies by Laparotomy. EMC-Gynecology Obstetrics, 2, 377-383.
https://doi.org/10.1016/j.emcgo.2005.08.001
[16]
Puech, F. (2011) Update on the Management of Myomas: Recommendations for Clinical Practice, Recommandation Text; Journal of Obstetrics Gynecology and Reproductive Biology. EM-Consult, Elsevier Masson, Amsterdam, 40.
[17]
Hamad, F.A., Trabelsi, D., Abidi, W., et al. (2020) Uterine Fibroma: Epidemiology Study and Therapeutic Management. Transylvanian Review.
[18]
Davitian, C., Ducarme, G., Rodrigues, A.B., et al. (2005) Myomectomies: Prevention of Bleeding. EMC-Gynecology Obstetrics, 2, 384-390.
https://doi.org/10.1016/j.emcgo.2005.08.004